{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T03:55:14Z","timestamp":1769918114758,"version":"3.49.0"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,6,10]]},"DOI":"10.7759\/cureus.62070","type":"journal-article","created":{"date-parts":[[2024,6,10]],"date-time":"2024-06-10T15:27:42Z","timestamp":1718033262000},"source":"Crossref","is-referenced-by-count":1,"title":["Acyclovir as a Novel Treatment for Severe Chronic Active Epstein-Barr Virus"],"prefix":"10.7759","author":[{"given":"Mary Therese","family":"Thomas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip","family":"Mardock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kedareeshwar S","family":"Arukala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2022.08.026","article-title":"Epstein-Barr virus: biology and clinical disease","volume":"185","author":"Damania B","year":"2022","unstructured":"Damania B, Kenney SC, Raab-Traub N. Epstein-Barr virus: biology and clinical disease. Cell. 2022, 185:3652-70. 10.1016\/j.cell.2022.08.026","journal-title":"Cell"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2018.03.001","article-title":"Primary Epstein-Barr virus infection","volume":"102","author":"Dunmire SK","year":"2018","unstructured":"Dunmire SK, Verghese PS, Balfour HH Jr. Primary Epstein-Barr virus infection. J Clin Virol. 2018, 102:84-92. 10.1016\/j.jcv.2018.03.001","journal-title":"J Clin Virol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.2147\/IDR.S434929","article-title":"A case of adult Epstein-Barr virus-associated pneumonia with multiple cavitary pulmonary lesions confirmed by lung biopsy mNGS: a case report","volume":"16","author":"Zhuang S","year":"2023","unstructured":"Zhuang S, Yu X, Zhang Y, Chen X. A case of adult Epstein-Barr virus-associated pneumonia with multiple cavitary pulmonary lesions confirmed by lung biopsy mNGS: a case report. Infect Drug Resist. 2023, 16:7507-13. 10.2147\/IDR.S434929","journal-title":"Infect Drug Resist"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.48.5.1351","article-title":"Epstein-Barr virus encephalomyelitis diagnosed by polymerase chain reaction: detection of the genome in the CSF","volume":"48","author":"Tselis A","year":"1997","unstructured":"Tselis A, Duman R, Storch GA, Lisak RP. Epstein-Barr virus encephalomyelitis diagnosed by polymerase chain reaction: detection of the genome in the CSF. Neurology. 1997, 48:1351-5. 10.1212\/wnl.48.5.1351","journal-title":"Neurology"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.1999.00806.x","article-title":"Ascites and severe hepatitis complicating Epstein-Barr infection","volume":"94","author":"Devereaux CE","year":"1999","unstructured":"Devereaux CE, Bemiller T, Brann O. Ascites and severe hepatitis complicating Epstein-Barr infection. Am J Gastroenterol. 1999, 94:236-40. 10.1111\/j.1572-0241.1999.00806.x","journal-title":"Am J Gastroenterol"},{"key":"ref6","article-title":"Mild infectious mononucleosis presenting with transient mixed liver disease: case report with a literature review","volume":"53","author":"Lawee D","year":"2007","unstructured":"Lawee D. Mild infectious mononucleosis presenting with transient mixed liver disease: case report with a literature review. Can Fam Physician. 2007, 53:1314-6.","journal-title":"Can Fam Physician"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1136\/adc.63.4.432","article-title":"Liver failure and Epstein-Barr virus infection","volume":"63","author":"Shaw NJ","year":"1988","unstructured":"Shaw NJ, Evans JH. Liver failure and Epstein-Barr virus infection. Arch Dis Child. 1988, 63:432-3. 10.1136\/adc.63.4.432","journal-title":"Arch Dis Child"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2020-037505","article-title":"Global and regional incidence, mortality and disability-adjusted life-years for Epstein-Barr virus-attributable malignancies, 1990-2017","volume":"10","author":"Khan G","year":"2020","unstructured":"Khan G, Fitzmaurice C, Naghavi M, Ahmed LA. Global and regional incidence, mortality and disability-adjusted life-years for Epstein-Barr virus-attributable malignancies, 1990-2017. BMJ Open. 2020, 10:e037505. 10.1136\/bmjopen-2020-037505","journal-title":"BMJ Open"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1128\/CDLI.7.3.451-456.2000","article-title":"Evaluation of 12 commercial tests for detection of Epstein-Barr virus-specific and heterophile antibodies","volume":"7","author":"Bruu AL","year":"2000","unstructured":"Bruu AL, Hjetland R, Holter E, et al.. Evaluation of 12 commercial tests for detection of Epstein-Barr virus-specific and heterophile antibodies. Clin Diagn Lab Immunol. 2000, 7:451-6. 10.1128\/CDLI.7.3.451-456.2000","journal-title":"Clin Diagn Lab Immunol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3390\/cancers10060197","article-title":"Antiviral drugs for EBV","volume":"10","author":"Pagano JS","year":"2018","unstructured":"Pagano JS, Whitehurst CB, Andrei G. Antiviral drugs for EBV. Cancers (Basel). 2018, 10:197. 10.3390\/cancers10060197","journal-title":"Cancers (Basel)"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1080\/00365549950164409","article-title":"Acyclovir for treatment of infectious mononucleosis: a meta-analysis","volume":"31","author":"Torre D","year":"1999","unstructured":"Torre D, Tambini R. Acyclovir for treatment of infectious mononucleosis: a meta-analysis. Scand J Infect Dis. 1999, 31:543-7. 10.1080\/00365549950164409","journal-title":"Scand J Infect Dis"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2010.07.008","article-title":"Antiviral treatment for severe EBV infections in apparently immunocompetent patients","volume":"49","author":"Rafailidis PI","year":"2010","unstructured":"Rafailidis PI, Mavros MN, Kapaskelis A, Falagas ME. Antiviral treatment for severe EBV infections in apparently immunocompetent patients. J Clin Virol. 2010, 49:151-7. 10.1016\/j.jcv.2010.07.008","journal-title":"J Clin Virol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-11-316745","article-title":"Characterization and treatment of chronic active Epstein-Barr virus disease: a 28-year experience in the United States","volume":"117","author":"Cohen JI","year":"2011","unstructured":"Cohen JI, Jaffe ES, Dale JK, et al.. Characterization and treatment of chronic active Epstein-Barr virus disease: a 28-year experience in the United States. Blood. 2011, 117:5835-49. 10.1182\/blood-2010-11-316745","journal-title":"Blood"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/247720-acyclovir-as-a-novel-treatment-for-severe-chronic-active-epstein-barr-virus","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,10]],"date-time":"2024-06-10T15:27:47Z","timestamp":1718033267000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/247720-acyclovir-as-a-novel-treatment-for-severe-chronic-active-epstein-barr-virus"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,10]]},"references-count":13,"URL":"https:\/\/doi.org\/10.7759\/cureus.62070","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6,10]]}}}